Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma

被引:71
作者
Ledermann, Jonathan A. [1 ,2 ]
Luvero, Daniela [1 ,2 ]
Shafer, Aaron [3 ]
O'Connor, Dennis [4 ]
Mangili, Giorgia [5 ]
Friedlander, Michael [6 ]
Pfisterer, Jacobus [7 ]
Mirza, Mansoor R. [8 ]
Kim, Jae-Weon [9 ]
Alexandre, Jerome [10 ]
Oza, Amit [11 ]
Brown, Jubilee [12 ]
机构
[1] UCL Canc Inst, London W1T 4TJ, England
[2] UCL Hosp, London, England
[3] Hartford Hosp, Hartford, CT 06115 USA
[4] Univ Louisville, Sch Med, Louisville, KY 40292 USA
[5] IRCCS San Raffaele Hosp, Milan, Italy
[6] Prince Wales Hosp Randwick, Randwick, NSW, Australia
[7] Gynecol Oncol Ctr, Kiel, Germany
[8] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[9] Seoul Natl Univ, Coll Med, Seoul, South Korea
[10] Paris Descartes Univ, Cochin Hotel Dieu, Paris, France
[11] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[12] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
Mucinous ovarian cancer; Mucinous tumor; BORDERLINE TUMORS; INTESTINAL-TYPE; CHEMOTHERAPY; WOMEN; ADENOCARCINOMAS; PREVALENCE; MUTATIONS; SUBTYPES;
D O I
10.1097/IGC.0000000000000296
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mucinous carcinomas of the ovary can be primary or metastatic in origin. Improvements in the pathological diagnosis have increased the ability to distinguish between primary and metastatic ovarian cancers and shown that primary mucinous carcinomas are a rare subtype of ovarian cancer. Most tumors are diagnosed at an early stage, and the prognosis after surgery is good. Advanced or recurrent mucinous carcinoma of the ovary responds poorly to current cytotoxic treatments, and the prognosis is poor. Here, we review the guidelines for surgery and the results of treatment of advanced and recurrent disease. Chemotherapy with platinum and paclitaxel is currently used to treat advanced disease, but the effect of these drugs is modest, and new treatments are needed.
引用
收藏
页码:S14 / S19
页数:6
相关论文
共 31 条
[1]   Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience [J].
Alexandre, J. ;
Ray-Coquard, I. ;
Selle, F. ;
Floquet, A. ;
Cottu, P. ;
Weber, B. ;
Falandry, C. ;
Lebrun, D. ;
Pujade-Lauraine, E. .
ANNALS OF ONCOLOGY, 2010, 21 (12) :2377-2381
[2]   Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas [J].
Anglesio, Michael S. ;
Kommoss, Stefan ;
Tolcher, Mary C. ;
Clarke, Blaise ;
Galletta, Laura ;
Porter, Henry ;
Damaraju, Sambasivarao ;
Fereday, Sian ;
Winterhoff, Boris J. ;
Kalloger, Steve E. ;
Senz, Janine ;
Yang, Winnie ;
Steed, Helen ;
Allo, Ghassan ;
Ferguson, Sarah ;
Shaw, Patricia ;
Teoman, Attila ;
Garcia, Joaquin J. ;
Schoolmeester, John K. ;
Bakkum-Gamez, Jamie ;
Tinker, Anna V. ;
Bowtell, David D. ;
Huntsman, David G. ;
Gilks, C. Blake ;
McAlpine, Jessica N. .
JOURNAL OF PATHOLOGY, 2013, 229 (01) :111-120
[3]  
Beral V, 2012, LANCET ONCOL, V13, P946, DOI [10.1016/S1470-2045(12)70322-4, 10.1016/S1470-2045(12)70365-0]
[4]   Histologic subtypes and laterality of primary epithelial ovarian tumors [J].
Boger-Megiddo, I ;
Weiss, NS .
GYNECOLOGIC ONCOLOGY, 2005, 97 (01) :80-83
[5]   Ovarian Intestinal Type Mucinous Borderline Tumors: Are We Ready for a Nomenclature Change? [J].
Chiesa, Andres G. ;
Deavers, Michael T. ;
Veras, Emanuela ;
Silva, Elvio G. ;
Gershenson, David ;
Malpica, Anais .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (02) :108-112
[6]   Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? [J].
Cho, Yun-Hyun ;
Kim, Dae-Yeon ;
Kim, Jong-Hyeok ;
Kim, Yong-Man ;
Kim, Kyu-Rae ;
Kim, Young-Tak ;
Nam, Joo-Hyun .
GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :878-882
[7]   Unmasking the complexities of mucinous ovarian carcinoma [J].
Frumovitz, Michael ;
Schmeler, Kathleen M. ;
Malpica, Anais ;
Sood, Anil K. ;
Gershenson, David M. .
GYNECOLOGIC ONCOLOGY, 2010, 117 (03) :491-496
[8]   Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment [J].
Hess, V ;
A'Hern, R ;
Nasiri, N ;
King, DM ;
Blake, PR ;
Barton, DPJ ;
Shepherd, JH ;
Ind, T ;
Bridges, J ;
Harrington, K ;
Kaye, SB ;
Gore, ME .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1040-1044
[9]   Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma [J].
Kelemen, Linda E. ;
Koebel, Martin .
LANCET ONCOLOGY, 2011, 12 (11) :1071-1080
[10]   Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype [J].
Kelly, Paul J. ;
Archbold, Pooler ;
Price, John H. ;
Cardwell, Chris ;
McCluggage, W. Glenn .
JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (02) :169-173